Drugs Made In America Acquisition Cash Flow Statement (2025) | DMAA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	1.25M	2.29M	2.18M	0.21M
Cash from Operations (Quarter)	-0.25M	-0.11M	-0.06M	-0.13M
Change in Working Capital
Change in Accured Expenses (Quarter)	0.06M	0.01M	0.16M	-0.08M
Investing Activities
Cash from Investing Activities (Quarter)	-231.15M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter)	228.85M	-225.65M	225.65M	-225.65M
Misc.
Cash from Financing Activities (Quarter)	231.40M	0.11M	0.06M	0.13M
Change in Cash (Quarter)	-428.00	-101.00	-105.00	0.01M
Beginning Cash Balance (Quarter)	0.90M
Free Cash Flow (Quarter)	-0.25M	-0.11M	-0.06M	-0.13M
Net Cash Flow (Quarter)	-428.00	-101.00	-105.00	0.01M